Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 1/20 | 0.72 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.72 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | CDC25B | P30305 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.43 |
| ▸ | TP53 | P04637 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | CASP1 | P29466 | 3/20 | 0.43 |
| ▸ | CASP7 | P55210 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.42 |
| ▸ | PRKCH | P24723 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pixantrone SCHEMBL29372192 | 1.00 | ECE1 (0.72) | ECE1MUS81KDM4CMAOAMAOB | |
| Pixantrone SCHEMBL17673194 | 0.98 | ECE1 (0.70) | ECE1MUS81KDM4CMAOAMAOB | |
| Pixantrone SCHEMBL7771183 | 0.98 | ECE1 (0.70) | ECE1MUS81KDM4CMAOAMAOB | |
| SCHEMBL28381205 | 0.93 | ECE1 (0.65) | ECE1MUS81KDM4CMAOAMAOB | |
| SCHEMBL29642348 | 0.93 | ECE1 (0.65) | ECE1MUS81KDM4CMAOAMAOB | |
| SCHEMBL28381199 | 0.93 | ECE1 (0.65) | ECE1MUS81KDM4CMAOAMAOB | |
| SCHEMBL28378350 | 0.93 | ECE1 (0.65) | ECE1MUS81KDM4CMAOAMAOB | |
| SCHEMBL13524774 | 0.93 | ECE1 (0.68) | ECE1MUS81KDM4CMAOAMAOB | |
| SCHEMBL29642192 | 0.93 | ECE1 (0.65) | ECE1MUS81KDM4CMAOAMAOB | |
| SCHEMBL29642322 | 0.93 | ECE1 (0.65) | ECE1MUS81KDM4CMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 14938 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101236-A1 | PEPTIDES SPECIFICALLY BINDING TO CCR8, AND USE THEREOF | 경희대학교 산학협력단 | 2026-05-15 | — | — | WO | claimed |
| EP-4737898-A2 | SEPARATION AND ISOLATION OF NUCLEIC ACIDS USING AFFINITY LIGANDS BOUND TO A SOLID SURFACE | EMP Biotech GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | claimed |
| US-20260085061-A1 | PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS | SITRYX THERAPEUTICS LIMITED (GB) | 2026-03-26 | — | — | US | claimed |
| EP-4692122-A1 | HUMANIZED ANTIBODIES TARGETING EPHA10 | Korea University Research and Business Foundation (KR) | 2026-02-11 | — | — | EP | claimed |
| US-20260000782-A1 | ITGB2-MEDIATED DRUG DELIVERY SYSTEM | TWINPIG BIOLAB INC. (KR) | 2026-01-01 | — | — | US | claimed |
| US-20250381202-A1 | PRODRUG KIT FOR MULTI-PRONGED CHEMOTHERAPY | ZOUNEK ALEX (DE) | 2025-12-18 | — | — | US | claimed |
| US-20250376507-A1 | NOVEL TUMOR ANTIGEN-TARGETING ANTICANCER AGENT | UNIV NAT CHONNAM IND FOUND (KR) | 2025-12-11 | — | — | US | claimed |
| EP-4640714-A2 | METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST | PML Screening, LLC (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4638443-A1 | TRANSIENT RECEPTOR POTENTIAL VANILLOID 6 INHIBITORS | Uniquest Pty Limited (AU) | 2025-10-29 | — | — | EP | claimed |
| WO-2001028521-A2 | LIPOSOME FORMULATION OF 6,9-BIS-[(2-AMINOETHYL)-AMINO]BENZO[G]ISOQUINOLINE-5,10-DIONE DIMALEATE | NOVUSPHARMA S.P.A. (IT) | 2001-04-26 | — | — | WO | claimed |
| EP-0503537-B1 | 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones | UNIV VERMONT (US) | 1997-05-14 | — | — | EP | claimed |
| US-5616709-A | Method of synthesis for 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt | BOEHRINGER MANNHEIM GMBH (IT) | 1997-04-01 | — | — | US | claimed |
| EP-0752857-A1 | AN IMPROVED METHOD OF SYNTHESIS FOR 6,9-BIS (2-AMINOETHYL)AMINO]BENZO g]ISOQUINOLINE-5,10-DIONE AND ITS DIMALEATE SALT | BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) | 1997-01-15 | — | — | EP | claimed |
| US-5587382-A | ANTITUMOR AGENTS | BOEHRINGER MANNHEIM ITALIA, SPA (IT) | 1996-12-24 | — | — | US | claimed |
| US-5506232-A | 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1996-04-09 | — | — | US | claimed |
| WO-1995026189-A1 | AN IMPROVED METHOD OF SYNTHESIS FOR 6,9-BIS[(2-AMINOETHYL)AMINO]BENZO[g]ISOQUINOLINE-5,10-DIONE AND ITS DIMALEATE SALT | BOEHRINGER MANNHEIM ITALIA, S.P.A. (US) | 1995-10-05 | — | — | WO | claimed |
| EP-0575526-A1 | 6,9 BIS(SUBSTITUTED-AMINO)BENZO g]ISOQUINOLINE-5,10-DIONES | THE UNIVERSITY OF VERMONT (US) | 1993-12-29 | — | — | EP | claimed |
| WO-1992015300-A1 | 6,9 BIS(SUBSTITUTED-AMINO)BENZO[g]ISOQUINOLINE-5,10-DIONES | THE UNIVERSITY OF VERMONT (US) | 1992-09-17 | — | — | WO | claimed |
| EP-0503537-A1 | 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones | THE UNIVERSITY OF VERMONT (US) | 1992-09-16 | — | — | EP | claimed |